Sargent Bickham Lagudis’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$691K Sell
8,887
-100
-1% -$8.11K 0.06% 155
2022
Q3
$726K Sell
8,987
-275
-3% -$24.7K 0.06% 145
2022
Q2
$831K Sell
9,262
-227
-2% -$23K 0.07% 145
2022
Q1
$1.05M Sell
9,489
-362
-4% -$38.2K 0.08% 134
2021
Q4
$1.02M Sell
9,851
-476
-5% -$55.1K 0.08% 132
2021
Q3
$1.29M Buy
10,327
+284
+3% +$36.8K 0.11% 118
2021
Q2
$1.25M Sell
10,043
-20
-0.2% -$2.51K 0.1% 120
2021
Q1
$1.19M Buy
10,063
+90
+0.9% +$10.5K 0.1% 115
2020
Q4
$1.17M Buy
9,973
+2,930
+42% +$323K 0.11% 115
2020
Q3
$732K Hold
7,043
0.07% 122
2020
Q2
$646K Sell
7,043
-35
-0.5% -$3.36K 0.07% 125
2020
Q1
$638K Buy
7,078
+5,846
+475% +$622K 0.08% 132
2019
Q4
$140K Buy
1,232
+1,049
+573% +$115K 0.02% 237
2019
Q3
$20K Buy
183
+60
+49% +$6.26K ﹤0.01% 475
2019
Q2
$12K Buy
123
+35
+40% +$3.2K ﹤0.01% 566
2019
Q1
$8K Hold
88
﹤0.01% 639
2018
Q4
$8K Hold
88
﹤0.01% 609
2018
Q3
$9K Buy
88
+18
+26% +$1.66K ﹤0.01% 620
2018
Q2
$6K Sell
70
-337
-83% -$28.1K ﹤0.01% 649
2018
Q1
$33K Hold
407
﹤0.01% 427
2017
Q4
$33K Sell
407
-200
-33% -$16K ﹤0.01% 431
2017
Q3
$47K Hold
607
0.01% 377
2017
Q2
$54K Hold
607
0.01% 349
2017
Q1
$49K Sell
607
-150
-20% -$11.7K 0.01% 361
2016
Q4
$54K Sell
757
-334
-31% -$26.2K 0.01% 327
2016
Q3
$94K Buy
1,091
+204
+23% +$17.8K 0.01% 272
2016
Q2
$77K Buy
887
+150
+20% +$12.1K 0.01% 287
2016
Q1
$55K Buy
+737
New +$55.5K 0.01% 349

Other funds holding MDT

Sargent Bickham Lagudis's MDT Position: Q4 2022 in Review

Sargent Bickham Lagudis reduced its Medtronic (MDT) stake by 1.1% in Q4 2022, selling an estimated $8.11K and leaving 8,887 shares worth $691K. The position accounts for 0.06% of the portfolio, ranked #155.

Sargent Bickham Lagudis first reported a position in MDT in Q1 2016 and has held it in 28 quarters since. The position peaked at $1.29M in Q3 2021. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Sargent Bickham Lagudis held 8,887 shares of Medtronic worth $691K as of Q4 2022.
  • Sargent Bickham Lagudis sold 100 Medtronic shares in Q4 2022, an estimated $8.11K.
  • Medtronic made up 0.06% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #155 holding.
  • Sargent Bickham Lagudis first reported a position in Medtronic in Q1 2016 and has held it in 28 quarters since.
  • Sargent Bickham Lagudis's Medtronic position peaked at $1.29M in Q3 2021.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.